Your browser doesn't support javascript.
loading
Exploring the Regulation of Jiangtang Tiaozhi Formula on the Biological Network of Obese T2DM Complicated With Dyslipidemia Based on Clinical Transcriptomics.
Bao, Tingting; Wang, Song; Yang, Yingying; He, Lisha; Han, Lin; Zhai, Tiangang; Chen, Jia; Zhou, Qiang; Zhao, Xiyan; Lian, Fengmei; Zhao, Linhua; Tong, Xiaolin.
Afiliação
  • Bao T; Graduate College, Beijing University of Chinese Medicine, Beijing, China.
  • Wang S; Institute of Metabolic Diseases, Guang' anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Yang Y; Department of Geriatrics, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • He L; National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Han L; Graduate College, Beijing University of Chinese Medicine, Beijing, China.
  • Zhai T; Institute of Metabolic Diseases, Guang' anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Chen J; Medical History Teaching and Research Department, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Zhou Q; Institute of Metabolic Diseases, Guang' anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Zhao X; Graduate College, Beijing University of Chinese Medicine, Beijing, China.
  • Lian F; Institute of Metabolic Diseases, Guang' anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Zhao L; Graduate College, Gansu University of Chinese Medicine, Lanzhou, China.
  • Tong X; Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
Front Endocrinol (Lausanne) ; 13: 817147, 2022.
Article em En | MEDLINE | ID: mdl-35957821
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Diabetes Mellitus Tipo 2 / Dislipidemias / RNA Longo não Codificante Limite: Humans Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Diabetes Mellitus Tipo 2 / Dislipidemias / RNA Longo não Codificante Limite: Humans Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça